Advertisement

Microalbuminuria and Mortality in Long-Duration Type 1 Diabetes

  1. Kate V. Allen, MRCP and
  2. James D. Walker, MD
  1. From the Department of Diabetes, Royal Infimary, Edinburgh, U.K.
  1. Address correspondence and reprint requests to Dr. James D. Walker, Department of Diabetes, Royal Infirmary, Edinburgh, EH3 9YW, Scotland. E-mail: james.walker{at}luht.scot.nhs.uk

Abstract

OBJECTIVE—Microalbuminuria is a recognized risk factor for increased mortality and renal failure in type 1 diabetes. Whether it remains a powerful predictor in patients with a long duration of type 1 diabetes is not known. We ascertained the prognostic significance of abnormal urinary albumin excretion in a cohort of patients with at least 30 years of type 1 diabetes.

RESEARCH DESIGN AND METHODS—A total of 190 patients with a disease duration of type 1 diabetes of at least 30 years with baseline and 5 years of follow-up.

RESULTS—At baseline 66% were normoalbuminuric, and at 5 years 11% of this cohort had died. Of the 22% who were microalbuminuric at baseline, 26% had died, and of the 8% with persistent proteinuria at baseline, 44% had died. Of the 4% with end-stage renal failure at baseline, 71% had died within 5 years. Death was attributable to a cardiovascular cause in two-thirds of the cases in all groups.

CONCLUSIONS—Even in those with a long duration of type 1 diabetes, the presence of abnormal urinary excretion remains a powerful predictor of increased mortality.

Footnotes

  • A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • Accepted May 9, 2003.
    • Received November 11, 2002.
| Table of Contents
Advertisement